Release Date: December 23, 2025
Expiration Date: December 23, 2026
Activity Overview
Schizophrenia represents a major psychiatric disorder characterized by symptoms that frequently compromise daily functioning and diminish overall quality of life. While effective management can lead to improved patient outcomes, many individuals continue to struggle with persistent or residual symptoms, medication adherence challenges, and adverse drug reactions. In particular, poor adherence to oral antipsychotic treatment increases the likelihood of symptom recurrence and psychiatric hospitalization. To address these challenges, long-acting injectable (LAI) antipsychotic formulations have been developed that offer advantages, such as eliminating the need for daily medication administration, maintaining more stable drug levels in the bloodstream, and facilitating consistent clinical oversight.
This educational program brings together clinical experts to examine how long-acting injectable antipsychotics can be effectively utilized in schizophrenia treatment, emphasizing their therapeutic benefits and safety profiles while exploring optimal strategies for incorporating these medications into personalized patient care approaches.
This educational activity is an archive of the live virtual symposium held at the Southern Florida Psychiatry conference on November 21, 2025.
Target Audience
This educational activity is directed toward psychiatrists who treat patients with a range of psychiatric disorders. Psychiatric nurse practitioners, psychiatric nurses, and other health care professionals interested in the treatment of patients with psychiatric disorders are invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better
prepared to:
- Review relevant clinical characteristics of long-acting injectable agents for schizophrenia
- Integrate long-acting injectable medications into individualized management plans for patients with schizophrenia
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here